UNSPSC 51422503: Amcinafide

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0Q1D55E29, chemically known as s! 15,112 but generally known as amcinafide, which bears US NIH Compound Identifier 23747. European Medicines Agency schedules Amcinafide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05403MIG. The term AMCINAFIDE is an International Non-Proprietary Name.

UNSPSC 51422503 Amcinafide is a Commodity code that encompasses pharmaceutical compounds and drug formulations procured by state and local health and emergency-response agencies. The recent solicitation record shows state and local governments using this code to procure naloxone and drug deactivation systems for community health and harm-reduction initiatives. Issuing bodies include county health departments and community health systems. The scope of work centers on the supply and delivery of pharmaceutical products and related systems to support public health operations, with vendors required to manage logistics, comply with drug-free workplace and E-Verify requirements, and maintain standard commercial insurance coverages.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid response deadline was July 26, 2023, at 2:00 pm, with all shipping and delivery costs included in vendor proposals. The contract structure includes an initial two-year term with a one-year renewal option and is potentially funded through FEMA, which subjects vendors to federal environmental and compliance audits. The procurement does not specify set-aside designations for disadvantaged enterprises. Florida represents the identified geographic center of recent activity under this code.